Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000942145 | SCV001088064 | benign | X-linked severe combined immunodeficiency | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004029722 | SCV004886849 | uncertain significance | Inborn genetic diseases | 2024-01-12 | criteria provided, single submitter | clinical testing | The c.759G>T (p.E253D) alteration is located in exon 6 (coding exon 6) of the IL2RG gene. This alteration results from a G to T substitution at nucleotide position 759, causing the glutamic acid (E) at amino acid position 253 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV000942145 | SCV002087220 | likely benign | X-linked severe combined immunodeficiency | 2020-02-17 | no assertion criteria provided | clinical testing |